Benzinga | Nov 10, 2020 04:48PM EST

Avidity Biosciences Q3 EPS $(0.31) Up From $(2.43) YoY, Sales $1.75M Up From $650.00K YoY

Avidity Biosciences (NASDAQ:RNA) reported quarterly losses of $(0.31) per share. This is a 87.24 percent increase over losses of $(2.43) per share from the same period last year. The company reported $1.75 million in sales this quarter. This is a 168.62 percent increase over sales of $650.00 thousand the same period last year.